Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host cell transcriptional machinery is a complex multi-component system, primarily centered around RNA polymerase II (Pol II), responsible for the synthesis of messenger RNA (mRNA) from DNA templates (Source: Nature Reviews Molecular Cell Biology, 2017). This machinery includes a vast array of general transcription factors (GTFs), co-activators, and cyclin-dependent kinases like CDK9, which are essential for the initiation, elongation, and termination of transcription (Source: UniProt). In the context of viral infections, many viruses, such as HIV-1 and SARS-CoV-2, hijack this host apparatus to express their own genomes (Source: Cell Host & Microbe, 2020). In oncology, the machinery is often dysregulated, leading to the constitutive expression of growth-promoting genes like MYC (Source: Trends in Cancer, 2018). Therapeutic agents like Actinomycin D and Flavopiridol target this machinery by intercalating DNA or inhibiting regulatory kinases, respectively (Source: PubChem). However, because transcription is a fundamental life process, targeting this machinery often results in significant systemic toxicity and a narrow therapeutic window (Source: NIH/StatPearls).
Inhibition of RNA polymerase II activity, blockade of transcription initiation or elongation, and inhibition of cyclin-dependent kinases (CDKs) that regulate the transcriptional cycle.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell transcriptional machinery.